Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Annals of General Psychiatry
Published in: Annals of General Psychiatry 1/2010

Open Access 01-04-2010 | Meeting abstract

CSF Potential Biomarkers Aβ42 and Tau: associations of Apo E Genotype

Authors: Ramesh Kandimalla, KD Gill, SK Prabhakar

Published in: Annals of General Psychiatry | Special Issue 1/2010

Login to get access

Excerpt

The most promising strategy to detect AD in preclinical or presymptomatic stage need specific biomarkers. In this study we elucidated the relationship between Apo E genotype and CSF biomarkers Aβ42 and Total tau in Alzheimer's Disease (AD) Patients, Non AD (NAD) patients, Neurological controls (NCs) and Healthy Controls (HCs). …
Literature
1.
Wenham PR, Price WH, Blandell G: Apolipoprotein E genotyping by one-stage PCR. Lancet. 1991, 337: 1158-9. 10.1016/0140-6736(91)92823-K.CrossRefPubMed
2.
Tapiola T, Pirttila T, Mehta PD, Alafuzofff I, Lehtovirta M, Soininen H: Relationship between apoE genotype and CSF beta-amyloid (1-42) and tau in patients with probable and definite Alzheimer's disease. Neurobiol Aging. 2000, 2: 735-40. 10.1016/S0197-4580(00)00164-0.CrossRef
3.
Riemenschneider M, Schmolke M, Lautenschlager N, Vanderstichele H, Vanmechelen E, Guder WG, et al: Association of CSF apolipoprotein E, Abeta42 and cognition in Alzheimer's disease. Neurobiol Aging. 2002, 23: 205-11. 10.1016/S0197-4580(01)00272-X.CrossRefPubMed
4.
Petersen RC, Smith GE, Ivnik RJ, Tangalos EG, Schaid DJ, Thibodeau SN, et al: Apolipoprotein E status as a predictor of the development of Alzheimer's disease in memory-impaired individuals. JAMA. 1995, 273: 1274-8. 10.1001/jama.273.16.1274.CrossRefPubMed
Metadata
Title
CSF Potential Biomarkers Aβ42 and Tau: associations of Apo E Genotype
Authors
Ramesh Kandimalla
KD Gill
SK Prabhakar
Publication date
01-04-2010
Publisher
BioMed Central
Published in
Annals of General Psychiatry / Issue Special Issue 1/2010
Electronic ISSN: 1744-859X
DOI
https://doi.org/10.1186/1744-859X-9-S1-S104

Other articles of this Special Issue 1/2010

Annals of General Psychiatry 1/2010 Go to the issue

Meeting abstract

Expression of NR1 subunit of NMDA receptor and PSD-93/95 in rat hippocampus affected by NR1/NR2 antisense oligodeoxynucleotide

Meeting abstract

Cross-cultural psychopharmacology: a review

Meeting abstract

Effect of the Greek Solutions for Wellness weight management program on quality of life and associated factors in patients with a psychiatric disorder receiving psychotropic medication

Meeting abstract

Suicide among untreated and treated depressives: the role of compliance, drug-resistance and underlying bipolarity

Meeting abstract

The Expressive and the Receptive One Word Picture Vocabulary test (EOWPVT & ROWPVT). (A combine pilot study and validation of the tests' in normal Greek population - aged from 17 years till 17 years and 11 months)

Meeting abstract

Prevalence of cataract in adult Down's syndrome patients